MedPath

Squalene

Generic Name
Squalene
Drug Type
Small Molecule
Chemical Formula
C30H50
CAS Number
111-02-4
Unique Ingredient Identifier
7QWM220FJH

Overview

Squalene is originally obtained from shark liver oil. It is a natural 30-carbon isoprenoid compound and intermediate metabolite in the synthesis of cholesterol. It is not susceptible to lipid peroxidation and provides skin protection. It is ubiquitously distributed in human tissues where it is transported in serum generally in association with very low density lipoproteins. Squalene is investigated as an adjunctive cancer therapy.

Background

Squalene is originally obtained from shark liver oil. It is a natural 30-carbon isoprenoid compound and intermediate metabolite in the synthesis of cholesterol. It is not susceptible to lipid peroxidation and provides skin protection. It is ubiquitously distributed in human tissues where it is transported in serum generally in association with very low density lipoproteins. Squalene is investigated as an adjunctive cancer therapy.

Indication

临床用于促进造血功能恢复,提高外周血中白细胞数量。还用于各种缺氧性疾病、心脏病、肝炎、癌症的防治。

Associated Conditions

  • Mild Joint Pain

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor

No clinical trials found

No clinical trials found for this drug

FDA Approved Products

Product Name
Manufacturer
Route
Strength
Approved
NDC Code

No FDA products found

No FDA products found for this drug

EMA Approved Products

Medicine Name
EMA Number
Auth. Holder
Country
Drug Type
Status
Issued
Opinion
Revision

No EMA products found

No EMA products found for this drug

HSA Approved Products

Product Name
Manufacturer
Dosage Form
Strength
Approved
Approval No.

No HSA products found

No HSA products found for this drug

NMPA Approved Products

Product Name
Approval No.
Manufacturer
Dosage Form
Trade Name
Strength
Type
Status
Date
Import
国药准字H33021879
胶囊剂
N/A
0.25g
Chemical Drug
Approved
2020/04/01
Domestic
国药准字H44024657
软胶囊剂
N/A
0.25g
Chemical Drug
Approved
2024/04/26
Domestic
国药准字H51023900
胶囊剂
N/A
0.25g
Chemical Drug
Approved
2021/03/15
Domestic
国药准字H32026379
胶囊剂(软胶囊)
N/A
0.25g
Chemical Drug
Approved
2020/07/30
Domestic
国药准字H44024670
胶囊剂(软胶囊)
N/A
0.25g
Chemical Drug
Approved
2015/05/28
Domestic
国药准字H20046462
胶囊剂(软胶囊)
N/A
0.5g
Chemical Drug
Approved
2015/06/02
Domestic
国药准字H44024679
胶囊剂
N/A
0.25g
Chemical Drug
Approved
2020/02/20
Domestic
国药准字H20058371
胶囊剂
N/A
0.25g
Chemical Drug
Approved
2021/07/14
Domestic
国药准字H44024658
胶囊剂(软胶囊)
N/A
0.5g
Chemical Drug
Approved
2024/04/26
Domestic
国药准字H23023064
胶囊剂
N/A
0.25g
Chemical Drug
Approved
2015/09/25
Domestic

PPB Approved Products

Product Name
Registration Code
Company
Category
Sale Type
Reg. Date

No PPB products found

No PPB products found for this drug

TGA Approved Products

Product Name
ARTG ID
Sponsor
Status
Reg. Date
Ingredient
160469
Active
2009/03/26
squalene
72121
Active
1999/11/30
squalene
51286
Forest Pharmatech Pty Limited
Active
1995/01/05
squalene
192163
Active
2011/11/17
squalene
123331
H & H International Technology Pty Ltd
Active
2005/11/03
squalene
323161
Active
2019/09/13
squalene
63685
Active
1998/03/26
squalene
97806
Kelbra Holdings Pty Ltd
Active
2003/10/28
squalene
449367
Active
2024/05/22
squalene
122912
Active
2005/10/19
squalene
© Copyright 2025. All Rights Reserved by MedPath